Advertisement
Screener

OLEMA PHARMACEUTICALS, INC. (OLMA) ROA

OLEMA PHARMACEUTICALS, INC. (OLMA) ROA

  • 2026-06-30: ROA -42.04%.
  • 2026-03-31: ROA -34.89%.
  • 2025-12-31: ROA -30.45%.
  • 2025-09-30: ROA -42.55%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-42.04%
2026-03-31-34.89%
2025-12-31-30.45%
2025-09-30-42.55%
2025-06-30-37.25%
2025-03-31-31.47%
2024-12-31-28.71%
2024-09-30-53.30%
2024-06-30-43.07%
2024-03-31-37.67%
2023-12-31-34.90%
2023-09-30-32.81%
2023-06-30-54.77%
2023-03-31-56.21%
2022-12-31-48.59%
2022-09-30-43.21%
2022-06-30-38.00%
2022-03-31-28.40%
2021-12-31-24.02%
2021-09-30-19.23%
2021-06-30-15.43%
2021-03-31-10.80%
2020-12-31-6.45%

Annual ROA

DateROA
2025-12-31-30.45%
2024-12-31-28.71%
2023-12-31-34.90%
2022-12-31-48.59%
2021-12-31-24.02%
2020-12-31-6.45%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
GERON CORP (GERN)United States$0.803B-12.14
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Faeth Therapeutics, Inc. (FTH)United States$0.750B
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74